These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 1424336)
21. Elevation of plasma atrial natriuretic peptide in rats with chronic heart failure by SCH 39370, a neutral metalloendopeptidase inhibitor. Tikkanen I; Helin K; Tikkanen T; Sybertz EJ; Vemulapalli S; Sariola H; Näveri H; Fyhrquist F J Pharmacol Exp Ther; 1990 Aug; 254(2):641-5. PubMed ID: 2143536 [TBL] [Abstract][Full Text] [Related]
22. Prognostic value of cardiac troponin T in patients with both acute and chronic stable congestive heart failure: comparison with atrial natriuretic peptide, brain natriuretic peptide and plasma norepinephrine. Bertinchant JP; Combes N; Polge A; Fabbro-Peray P; Raczka F; Beck L; Cade S; Ledermann B Clin Chim Acta; 2005 Feb; 352(1-2):143-53. PubMed ID: 15653109 [TBL] [Abstract][Full Text] [Related]
23. [The examination of clinical prognostic importance of atrial and brain natriuretic peptide in patients with acute myocardial infarction]. Mazurek W; Salomon P Pol Merkur Lekarski; 2002 Jan; 12(67):15-9. PubMed ID: 11957795 [TBL] [Abstract][Full Text] [Related]
24. Which of the cardiac natriuretic peptides is most effective for the treatment of congestive heart failure, renal failure and cancer? Vesely DL Clin Exp Pharmacol Physiol; 2006 Mar; 33(3):169-76. PubMed ID: 16487258 [TBL] [Abstract][Full Text] [Related]
25. [Secretion and clinical significance of atrial natriuretic peptide in patients with muscular dystrophy]. Kimura C; Kawai H; Adachi K; Nishiuchi T; Saito S Rinsho Shinkeigaku; 1989 Mar; 29(3):290-5. PubMed ID: 2526701 [TBL] [Abstract][Full Text] [Related]
27. Implications of the natriuretic peptide system in the pathogenesis of heart failure: diagnostic and therapeutic importance. Abassi Z; Karram T; Ellaham S; Winaver J; Hoffman A Pharmacol Ther; 2004 Jun; 102(3):223-41. PubMed ID: 15246247 [TBL] [Abstract][Full Text] [Related]
28. Plasma levels of brain natriuretic peptide as an index for evaluation of cardiac function in female gene carriers of Duchenne muscular dystrophy. Adachi K; Kawai H; Saito M; Naruo T; Kimura C; Mine H; Inui T; Kashiwagi S; Akaike M Intern Med; 1997 Jul; 36(7):497-500. PubMed ID: 9240500 [TBL] [Abstract][Full Text] [Related]
29. Atrial natriuretic peptide and the development of congestive heart failure in the oldest old: a seven-year prospective study. Knight EL; Fish LC; Kiely DK; Marcantonio ER; Davis KM; Minaker KL J Am Geriatr Soc; 1999 Apr; 47(4):407-11. PubMed ID: 10203114 [TBL] [Abstract][Full Text] [Related]
30. Atrial natriuretic peptide levels in the prediction of congestive heart failure risk in frail elderly. Davis KM; Fish LC; Elahi D; Clark BA; Minaker KL JAMA; 1992 May; 267(19):2625-9. PubMed ID: 1533427 [TBL] [Abstract][Full Text] [Related]
31. Relationship of natriuretic peptide and transthoracic echocardiographic findings in 135 subjects with muscular dystrophy. Kawakubo M; Funabashi N; Takahashi M; Sueishi M; Motoyoshi Y; Mikata T; Uchida I; Asakawa T; Takahashi R; Takamatsu M; Matsuoka Y; Minegishi M; Naga H; Yajima R; Kataoka A; Lee K; Komuro I Int J Cardiol; 2010 Dec; 145(3):506-14. PubMed ID: 20061036 [No Abstract] [Full Text] [Related]
32. Prognostic evaluation of congestive heart failure in patients with Duchenne muscular dystrophy--retrospective study using non-invasive cardiac function tests. Nagai T Jpn Circ J; 1989 May; 53(5):406-15. PubMed ID: 2769928 [TBL] [Abstract][Full Text] [Related]
33. Relationships between plasma levels of catecholamines and neuropeptides and the survival time in patients with congestive heart failure. Valdemarsson S; Bergdahl A; Edvinsson L J Intern Med; 1994 Jun; 235(6):595-601. PubMed ID: 8207366 [TBL] [Abstract][Full Text] [Related]
34. Changes of molecular forms of atrial natriuretic peptide after treatment for congestive heart failure. Marumo F; Kurosawa T; Takeda S; Katoh Y; Hasegawa N; Ando K Klin Wochenschr; 1988 Aug; 66(15):675-81. PubMed ID: 2971839 [TBL] [Abstract][Full Text] [Related]
35. [Preliminary exploration on effect of yiqi wenyang huoxue lishui treatment on neuroendocrine system in patients with congestive heart failure]. An HY; Huang LJ; Jin JS Zhongguo Zhong Xi Yi Jie He Za Zhi; 2002 May; 22(5):349-52. PubMed ID: 12584832 [TBL] [Abstract][Full Text] [Related]
36. Different factors affecting human ANP amyloid aggregation and their implications in congestive heart failure. Millucci L; Paccagnini E; Ghezzi L; Bernardini G; Braconi D; Laschi M; Consumi M; Spreafico A; Tanganelli P; Lupetti P; Magnani A; Santucci A PLoS One; 2011; 6(7):e21870. PubMed ID: 21814559 [TBL] [Abstract][Full Text] [Related]
37. [Cardiac involvement in progressive muscular dystrophy]. SCHLESINGER P; POMPEU F Med Cir Farm; 1959 Aug; No 280():338-49. PubMed ID: 14442884 [No Abstract] [Full Text] [Related]
38. Cardiac involvement in progressive muscular dystrophy of the Duchenne type. Ishikawa K Jpn Heart J; 1997 Mar; 38(2):163-80. PubMed ID: 9201104 [TBL] [Abstract][Full Text] [Related]